Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Phillip Berman
University of California Santa Cruz, Department: Engineering (All Types)
Should you be removed from our database? Contact us at [email protected]. Read more below.
Westcliff Genetics
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
The company intends to license intellectual property being used in and/or arising from the research.
Re-engineering gp120 to include glycan-dependent epitopes
The goal of this work is the development of a safe, effective, and affordable vaccine to prevent HIV-1 infection. Our approach is to develop vaccine immunogens that target glycan-dependent epitopes recognized by broadly neutralizing antibodies. By improving an existing vaccine extensively tested in human clinical trials rather than developing a new vaccine from scratch, years of time and millions of dollars can be saved in delivering this vaccine to populations at risk of infection by HIV-1.
Filed on September 02, 2014.
Tell us what you know about Phillip Berman's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Phillip Berman filed other conflict of interest disclosures with the NIH:
Name | Institution | Type | Company | Disclosed Value |
---|---|---|---|---|
Phillip Berman | University of California Santa Cruz | Conflict of Interest | StemCentRx | $40,000 - $59,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.